Abstract
Stem cells capable of differentiating to multiple lineages may be valuable for urological regenerative medicine. Recent research has described the presence in the amniotic fluid of stem cells with various differentiative and proliferative potentials. The use of amniotic fluid-derived stem cells does not present the same ethical challenges as the use of embryonic stem cells and the cells can be isolated using amniocentesis, a widely accepted procedure for prenatal diagnosis. This chapter summarizes the different progenitor cells that have been described so far in the amniotic fluid and the placenta and focuses in particular on mesenchymal stem cells and amniotic fluid-derived stem cells.
| Original language | English |
|---|---|
| Title of host publication | Biomaterials and Tissue Engineering in Urology |
| Publisher | Elsevier Ltd. |
| Pages | 378-394 |
| Number of pages | 17 |
| ISBN (Print) | 9781845694029 |
| DOIs | |
| State | Published - Apr 1 2009 |
| Externally published | Yes |
Fingerprint
ASJC Scopus subject areas
- Medicine(all)
- Dentistry(all)
Cite this
Amniotic fluid and placental stem cells as a source for urological regenerative medicine. / De Coppi, Paolo; Bartsch, Georg; Atala, Anthony.
Biomaterials and Tissue Engineering in Urology. Elsevier Ltd., 2009. p. 378-394.Research output: Chapter in Book/Report/Conference proceeding › Chapter
}
TY - CHAP
T1 - Amniotic fluid and placental stem cells as a source for urological regenerative medicine
AU - De Coppi, Paolo
AU - Bartsch, Georg
AU - Atala, Anthony
PY - 2009/4/1
Y1 - 2009/4/1
N2 - Stem cells capable of differentiating to multiple lineages may be valuable for urological regenerative medicine. Recent research has described the presence in the amniotic fluid of stem cells with various differentiative and proliferative potentials. The use of amniotic fluid-derived stem cells does not present the same ethical challenges as the use of embryonic stem cells and the cells can be isolated using amniocentesis, a widely accepted procedure for prenatal diagnosis. This chapter summarizes the different progenitor cells that have been described so far in the amniotic fluid and the placenta and focuses in particular on mesenchymal stem cells and amniotic fluid-derived stem cells.
AB - Stem cells capable of differentiating to multiple lineages may be valuable for urological regenerative medicine. Recent research has described the presence in the amniotic fluid of stem cells with various differentiative and proliferative potentials. The use of amniotic fluid-derived stem cells does not present the same ethical challenges as the use of embryonic stem cells and the cells can be isolated using amniocentesis, a widely accepted procedure for prenatal diagnosis. This chapter summarizes the different progenitor cells that have been described so far in the amniotic fluid and the placenta and focuses in particular on mesenchymal stem cells and amniotic fluid-derived stem cells.
UR - http://www.scopus.com/inward/record.url?scp=84902402573&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84902402573&partnerID=8YFLogxK
U2 - 10.1533/9781845696375.3.378
DO - 10.1533/9781845696375.3.378
M3 - Chapter
AN - SCOPUS:84902402573
SN - 9781845694029
SP - 378
EP - 394
BT - Biomaterials and Tissue Engineering in Urology
PB - Elsevier Ltd.
ER -